Potential of Gayo Arabica Coffee Skin

April 18, 2025 updated by: Wahyu Lestari

Potential of Gayo Arabica Coffee Skin Extract Cream as a Topical Antioxidant: Clinical Trials on Humans

The purpose of this study was to assess the effectiveness of gayo arabica coffee skin extract cream in the prevention of skin aging

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Indonesia
    • Nanggroe Aceh Darussalam
      • Banda Aceh, Nanggroe Aceh Darussalam, Indonesia, 23126
        • dr. Zainoel Abidin General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women.
  • have skin aging condition aged 30-60 years.
  • Willing to participate in research based on research protocols.
  • Before the research begins, research subjects are willing to sign informed consent and participate in the research until completion according to the research provisions from initial examination, re-control, and treatment until completion).

Exclusion Criteria:

  • History of allergy to one of the ingredients in the cream.
  • have a skin disorder and are undergoing treatment for skin disease.
  • Undergoing treatment and use of facial cream in the last 1 month.
  • History of allergy to coffee.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: skin aging patients
Drug: gayo arabica coffee skin extract cream
Assessment of glagou scale, skin analyzer, corneometer, and tewameter was done before and after the treatment . The subject will receive directions on how to use the cream before the study starts. The cream was used 2 times daily (7.40 AM and 1.00 PM) for 8 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glogau scale examination
Time Frame: 8 weeks from the beginning of the cream used by the subject
the objective of this examination was to determine wrinkles. this parameter was measured before and after the study and then compared to assess the improvement
8 weeks from the beginning of the cream used by the subject
Skin analyzer examination
Time Frame: 8 weeks from the beginning of the cream used by the subject
the objective of this examination was to determine skin moisture, pigmentation. this parameter was measured before and after the study and then compared to assess the improvement
8 weeks from the beginning of the cream used by the subject
Corneometer examination
Time Frame: 8 weeks from the beginning of the cream used by the subject
the objective of this examination was to determine skin hydration. this parameter was measured before and after the study and then compared to assess the improvement
8 weeks from the beginning of the cream used by the subject

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wahyu Lestari

Investigators

  • Principal Investigator: Wahyu Lestari, MD, Department of dermatology, venereology, and aesthetic dr. Zainoel Abidin General Hospital Banda Aceh, Nanggroe Aceh Darussalam, Indonesia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

April 9, 2025

First Submitted That Met QC Criteria

April 18, 2025

First Posted (Actual)

April 23, 2025

Study Record Updates

Last Update Posted (Actual)

April 23, 2025

Last Update Submitted That Met QC Criteria

April 18, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 094/ETIK-RSUDZA/2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

to ensure the confidentiality of data obtained from respondents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Aging

Clinical Trials on gayo arabica coffee skin extract cream

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe